Exercise Intervention to maintain endurance and mobility in patients undergoing allogenic hematopoetic stem cell transplantation (alloHCT)

Exercise Intervention to maintain endurance and mobility in patients undergoing allogenic hematopoetic stem cell transplantation (alloHCT) - MOTO-Pilot

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00005488

Enrollment

Registered

2014-02-04

Start date

2014-02-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C81-C96 D46

Interventions

Group 1: Patients in the intervention group are receiving an endurance training during hospitalization Group 2: Patients in the active control group are receiving balance training during hospitalizati

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - All patients eligible for alloHCT - Signed informed consent

Exclusion criteria

Exclusion criteria: - instable bone metastases

Design outcomes

Primary

Measure	Time frame
Endurance capacity, lactate diagnistics and spiroergometry (individaul anaerobic threshold, respiratory thresholds, watt) (Ergoline 900, Jaeger, Hoechberg, Germany)	—

Secondary

Measure	Time frame
- mobility [sway path (cm), chair rising test(s)]; - hand grip strength (kg); - body composition [phase angle (°), fat mass, fat-free mass (%), body cell mass(kg)]; - questionnaire (quality of life EORTC QLQ-C30, side effects)	—

Countries

Germany

Contacts

Public ContactMatthias Limbach

Zentrale Einrichtung Bewegungsmedizin und Sport

matthias.limbach@uniklinik-freiburg.de076127074930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026